Annex III F1
United Kingdom
List of programmes for the monitoring of TSEs as referred to in Article 3(1)
Rate and maximum amount of the Community financial contribution
| Disease | Member State | Rate rapid tests and discriminatory tests performed | Maximum amount (EUR) |
|---|---|---|---|
| TSEs | Belgium | 100 % | 2 084 000 |
| Czech Republic | 100 % | 1 320 000 | |
| Denmark | 100 % | 1 950 000 | |
| Germany | 100 % | 11 307 000 | |
| Estonia | 100 % | 233 000 | |
| Ireland | 100 % | 6 410 000 | |
| Greece | 100 % | 1 650 000 | |
| Spain | 100 % | 9 100 000 | |
| France | 100 % | 24 815 000 | |
| Italy | 100 % | 3 000 000 | |
| Cyprus | 100 % | 530 000 | |
| Latvia | 100 % | 312 000 | |
| Lithuania | 100 % | 645 000 | |
| Luxembourg | 100 % | 146 000 | |
| Hungary | 100 % | 784 000 | |
| Malta | 100 % | 90 000 | |
| Netherlands | 100 % | 5 112 000 | |
| Austria | 100 % | 1 759 000 | |
| Poland | 100 % | 244 000 | |
| Portugal | 100 % | 2 940 000 | |
| Romania | 100 % | 2 370 000 | |
| Slovenia | 100 % | 308 000 | |
| Slovakia | 100 % | 610 000 | |
| Finland | 100 % | 839 000 | |
| Sweden | 100 % | 2 020 000 | |
| United Kingdom | 100 % | 6 781 000 | |
| Total | 87 359 000 | ||